{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:22:21Z","timestamp":1789820541373,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ijpharm.2016.01.040","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T07:32:10Z","timestamp":1453361530000},"page":"162-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":164,"title":["Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation"],"prefix":"10.1016","volume":"500","author":[{"given":"Mona","family":"Alibolandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Abnous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Hosseinkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-8191","authenticated-orcid":false,"given":"Farzin","family":"Hadizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.01.040_bib0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2003.12.021","article-title":"Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles","volume":"96","author":"Ahmed","year":"2004","journal-title":"J. Controlled Release"},{"issue":"September (5)","key":"10.1016\/j.ijpharm.2016.01.040_bib0010","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s10895-014-1437-5","article-title":"Synthesis of AS1411-aptamer-conjugated CdTe quantum dots with high fluorescence strength for probe labeling tumor cells","volume":"24","author":"Alibolandi","year":"2014","journal-title":"J. Fluoresc."},{"issue":"July","key":"10.1016\/j.ijpharm.2016.01.040_bib0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2015.04.026","article-title":"In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer","volume":"209","author":"Alibolandi","year":"2015","journal-title":"J. Controlled Release"},{"issue":"August","key":"10.1016\/j.ijpharm.2016.01.040_bib0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejpb.2015.07.005","article-title":"The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model","volume":"94","author":"Alibolandi","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"February 1 (1)","key":"10.1016\/j.ijpharm.2016.01.040_bib0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2014.12.035","article-title":"Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro","volume":"479","author":"Alibolandi","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"September (16)","key":"10.1016\/j.ijpharm.2016.01.040_bib0030","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.2174\/1381612821666150917093543","article-title":"Current status of magnetite-based core@shell structures for diagnosis and therapy in oncology short biomedical applications of magnetite@shell structures","volume":"21","author":"Andrade","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"August 10 (3)","key":"10.1016\/j.ijpharm.2016.01.040_bib0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Controlled Release"},{"issue":"August (8)","key":"10.1016\/j.ijpharm.2016.01.040_bib0040","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1007\/s13277-015-3706-6","article-title":"Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy","volume":"36","author":"Bahrami","year":"2015","journal-title":"Tumour Biol."},{"issue":"October (7)","key":"10.1016\/j.ijpharm.2016.01.040_bib0045","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-14-0463","article-title":"Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer","volume":"20","author":"Bolyard","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"December (15)","key":"10.1016\/j.ijpharm.2016.01.040_bib0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bios.2015.06.012","article-title":"Gold nanoprobes-based resonance Rayleigh scattering assay platform: Sensitive cytosensing of breast cancer cells and facile monitoring of folate receptor expression","volume":"74","author":"Cai","year":"2015","journal-title":"Biosens. Bioelectron."},{"issue":"April","key":"10.1016\/j.ijpharm.2016.01.040_bib0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.biomaterials.2014.12.034","article-title":"Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking","volume":"46","author":"Chan","year":"2015","journal-title":"Biomaterials."},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-319-16555-4_5","article-title":"Theranostic lipid nanoparticles for cancer medicine","volume":"166","author":"Charron","year":"2015","journal-title":"Cancer Treat Res."},{"issue":"June 28 (3)","key":"10.1016\/j.ijpharm.2016.01.040_bib0065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2013.03.029","article-title":"Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging","volume":"168","author":"Chiang","year":"2013","journal-title":"J. Controlled Release"},{"issue":"June 28 (3)","key":"10.1016\/j.ijpharm.2016.01.040_bib0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2013.03.029","article-title":"Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging","volume":"168","author":"Chiang","year":"2013","journal-title":"J. Controlled Release"},{"issue":"3","key":"10.1016\/j.ijpharm.2016.01.040_bib0075","doi-asserted-by":"crossref","first-page":"e32920","DOI":"10.1371\/journal.pone.0032920","article-title":"Folate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance","volume":"7","author":"Das","year":"2012","journal-title":"PLoS One"},{"issue":"July (7)","key":"10.1016\/j.ijpharm.2016.01.040_bib0080","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/mabi.201300039","article-title":"Nanobody-functionalized polymersomes for tumor-vessel targeting","volume":"13","author":"Debets","year":"2013","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0085","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1074972","article-title":"Polymer vesicles","volume":"297","author":"Discher","year":"2002","journal-title":"Science"},{"issue":"5417","key":"10.1016\/j.ijpharm.2016.01.040_bib0090","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.284.5417.1143","article-title":"Polymersomes: tough vesicles made from diblock copolymers","volume":"284","author":"Discher","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijpharm.2016.01.040_bib0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00216-009-3033-0","article-title":"Bioconjugated quantum dots as fluorescent probes for bioanalytical applications","volume":"396","author":"Frasco","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"issue":"September 28 (5)","key":"10.1016\/j.ijpharm.2016.01.040_bib0100","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s13058-014-0446-2","article-title":"Risk determination and prevention of breast cancer","volume":"16","author":"Howell","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"October","key":"10.1016\/j.ijpharm.2016.01.040_bib0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biopha.2015.08.036","article-title":"Enhanced antitumor efficacy of folate targeted nanoparticles co-loaded with docetaxel and curcumin","volume":"75","author":"Hu","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"August 11 (5)","key":"10.1016\/j.ijpharm.2016.01.040_bib0110","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejps.2010.05.005","article-title":"Development of amphotericin B loaded polymersomes based on (PEG)(3)-PLA co-polymers: factors affecting size and in vitro evaluation","volume":"40","author":"Jain","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0168-3659(99)00061-9","article-title":"New biodegradable polymers for injectable drug delivery systems","volume":"62","author":"Jeong","year":"1999","journal-title":"J. Controlled Release"},{"issue":"February (2)","key":"10.1016\/j.ijpharm.2016.01.040_bib0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/10717544.2013.879964","article-title":"Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles","volume":"22","author":"Jiang","year":"2015","journal-title":"Drug Deliv."},{"issue":"June (6)","key":"10.1016\/j.ijpharm.2016.01.040_bib0125","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/mabi.201200448","article-title":"A biodegradable polymersome containing Bcl-xL siRNA and doxorubicin as a dual delivery vehicle for a synergistic anticancer effect","volume":"13","author":"Kim","year":"2013","journal-title":"Macromol. Biosci."},{"issue":"December 11 (1)","key":"10.1016\/j.ijpharm.2016.01.040_bib0130","first-page":"81","article-title":"Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?","volume":"4","author":"Kobayashi","year":"2013","journal-title":"Theranostics"},{"issue":"July 9 (13)","key":"10.1016\/j.ijpharm.2016.01.040_bib0135","doi-asserted-by":"crossref","first-page":"10821","DOI":"10.1021\/am502822n","article-title":"Tailoring polymersome bilayer permeability improves enhanced permeability and retention effect for bioimaging","volume":"6","author":"Lai","year":"2014","journal-title":"ACS Appl. Mater Interfaces"},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0140","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1161\/CIRCULATIONAHA.105.560250","article-title":"Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin","volume":"113","author":"Li","year":"2006","journal-title":"Circulation"},{"issue":"January\u2013February (1)","key":"10.1016\/j.ijpharm.2016.01.040_bib0145","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/bp060208","article-title":"Self-assembled poly(butadiene)-b-poly(ethylene oxide) polymersomes as paclitaxel carriers","volume":"23","author":"Li","year":"2007","journal-title":"Biotechnol. Prog."},{"issue":"March (9)","key":"10.1016\/j.ijpharm.2016.01.040_bib0150","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.biomaterials.2011.12.035","article-title":"Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking","volume":"33","author":"Li","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0155","doi-asserted-by":"crossref","first-page":"77986","DOI":"10.1039\/C5RA15313A","article-title":"Co-delivery of doxorubicin hydrochloride and verapamil hydrochloride by pH-sensitive polymersomes for the reversal of multidrug resistance","volume":"5","author":"Li","year":"2015","journal-title":"RSC Adv."},{"issue":"April (4)","key":"10.1016\/j.ijpharm.2016.01.040_bib0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1166\/jbn.2015.1945","article-title":"Theranostic polymeric micelles for the diagnosis and treatment of hepatocellular carcinoma","volume":"11","author":"Liu","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","article-title":"The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting","volume":"41","author":"Maeda","year":"2001","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0378-5173(93)90015-8","article-title":"A new in vitro technique for evaluation of drug release profile from colloidal carriers-ultrafiltration technique at low pressure","volume":"94","author":"Magenheim","year":"1993","journal-title":"Int. J. Pharm."},{"issue":"August 1 (3)","key":"10.1016\/j.ijpharm.2016.01.040_bib0180","first-page":"433","article-title":"An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patients","volume":"46","author":"Mattsson","year":"1980","journal-title":"Cancer"},{"issue":"January 3 (1\u20133)","key":"10.1016\/j.ijpharm.2016.01.040_bib0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2004.09.026","article-title":"Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting","volume":"101","author":"Meng","year":"2005","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0190","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejps.2009.11.010","article-title":"Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy","volume":"39","author":"Misra","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"issue":"October 9","key":"10.1016\/j.ijpharm.2016.01.040_bib0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2015.09.060","article-title":"Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy","volume":"218","author":"Moon","year":"2015","journal-title":"J. Controlled Release"},{"issue":"August (24)","key":"10.1016\/j.ijpharm.2016.01.040_bib0200","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1016\/j.biomaterials.2014.04.026","article-title":"Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells","volume":"35","author":"Nahire","year":"2014","journal-title":"Biomaterials"},{"issue":"December 1 (11)","key":"10.1016\/j.ijpharm.2016.01.040_bib0205","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/1097-0142(19801201)46:11<2380::AID-CNCR2820461113>3.0.CO;2-M","article-title":"Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy","volume":"46","author":"Nash","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0210","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/toxsci\/kfp188","article-title":"State of academic knowledge on toxicity and biological fate of quantum dots","volume":"112","author":"Pelley","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0215","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1039\/C4TB01102C","article-title":"Folate-modified bexarotene-loaded bovine serum albumin nanoparticles as a promising tumor-targeting delivery system","volume":"2","author":"Qi","year":"2014","journal-title":"J. Mater. Chem. B."},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0220","first-page":"567","article-title":"Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation","volume":"2","author":"Rahman","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0225","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/mp050032z","article-title":"Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention","volume":"2","author":"Sahoo","year":"2005","journal-title":"Mol. Pharm."},{"issue":"March (3)","key":"10.1016\/j.ijpharm.2016.01.040_bib0230","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1166\/jnn.2015.9761","article-title":"Multifunctional drug delivery systems using inorganic nanomaterials: a review","volume":"15","author":"Sao","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"August","key":"10.1016\/j.ijpharm.2016.01.040_bib0235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biomaterials.2015.03.039","article-title":"Synthesis of a novel, sequentially active-targeted drug delivery nanoplatform for breast cancer therapy","volume":"59","author":"Satsangi","year":"2015","journal-title":"Biomaterials"},{"issue":"June (6)","key":"10.1016\/j.ijpharm.2016.01.040_bib0240","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1039\/C5BM00077G","article-title":"Noninvasive theranostic imaging of HSV-TK\/GCV suicide gene therapy in liver cancer by folate-targeted quantum dot-based liposomes","volume":"3","author":"Shao","year":"2015","journal-title":"Biomater. Sci."},{"issue":"June (6)","key":"10.1016\/j.ijpharm.2016.01.040_bib0245","first-page":"833","article-title":"Dendrimers for theranostic applications","volume":"3","author":"Sk","year":"2015","journal-title":"Biomater. Sci."},{"issue":"July (10)","key":"10.1016\/j.ijpharm.2016.01.040_bib0250","first-page":"1499","article-title":"Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment","volume":"9","author":"Su","year":"2015","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0255","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","author":"Suk","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"May 14 (5)","key":"10.1016\/j.ijpharm.2016.01.040_bib0260","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/mabi.200900415","article-title":"In vitro and in vivo evaluation of docetaxel loaded biodegradable polymersomes","volume":"10","author":"Upadhyay","year":"2010","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2006.12.033","article-title":"Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines","volume":"337","author":"Wang","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"December","key":"10.1016\/j.ijpharm.2016.01.040_bib0270","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biomaterials.2015.08.048","article-title":"Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127 PLGA and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells","volume":"72","author":"Wang","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2016.01.040_bib0275","first-page":"1599","article-title":"Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging","volume":"7","author":"Wen","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"March 19 (3)","key":"10.1016\/j.ijpharm.2016.01.040_bib0280","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/ar3000585","article-title":"Quantum dot cytotoxicity and ways to reduce it","volume":"46","author":"Winnik","year":"2013","journal-title":"Acc. Chem. Res."},{"issue":"May 4 (5)","key":"10.1016\/j.ijpharm.2016.01.040_bib0285","doi-asserted-by":"crossref","first-page":"e0123461","DOI":"10.1371\/journal.pone.0123461","article-title":"Quantitative analysis of the enhanced permeation and retention (EPR) effect","volume":"10","author":"Wong","year":"2015","journal-title":"PLoS One"},{"issue":"August","key":"10.1016\/j.ijpharm.2016.01.040_bib0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.msec.2015.04.012","article-title":"Anti-tumor activity of folate targeted biodegradable polymer-paclitaxel conjugate micelles on EMT-6 breast cancer model","volume":"53","author":"Wu","year":"2015","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"February (2)","key":"10.1016\/j.ijpharm.2016.01.040_bib0295","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.nano.2013.08.004","article-title":"High loading of hydrophilic\/hydrophobic doxorubicin into polyphosphazene polymersome for breast cancer therapy","volume":"10","author":"Xu","year":"2014","journal-title":"Nanomedicine"},{"issue":"December (18)","key":"10.1016\/j.ijpharm.2016.01.040_bib0300","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.2217\/nnm.14.50","article-title":"Theranostic nanoemulsions: codelivery of hydrophobic drug and hydrophilic imaging probe for cancer therapy and imaging","volume":"9","author":"Yang","year":"2014","journal-title":"Nanomedicine (Lond.)"},{"issue":"September (9)","key":"10.1016\/j.ijpharm.2016.01.040_bib0305","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1166\/jbn.2015.2132","article-title":"Folate-modified poly(malic acid) graft polymeric nanoparticles for targeted delivery of doxorubicin: synthesis, characterization and folate receptor expressed cell specificity","volume":"11","author":"Yang","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"issue":"February 7 (3)","key":"10.1016\/j.ijpharm.2016.01.040_bib0310","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1039\/C2CS35392J","article-title":"Nanotoxicity ssessment of quantum dots: from cellular to primate studies","volume":"42","author":"Yong","year":"2013","journal-title":"Chem. Soc. Rev."},{"issue":"November 2 (45)","key":"10.1016\/j.ijpharm.2016.01.040_bib0315","doi-asserted-by":"crossref","first-page":"16162","DOI":"10.1002\/chem.201502177","article-title":"Near-infrared light and pH-responsive polypyrrole@polyacrylic acid\/fluorescent mesoporous silica nanoparticles for imaging and chemo-photothermal cancer therapy","volume":"21","author":"Zhang","year":"2015","journal-title":"Chemistry"},{"issue":"4","key":"10.1016\/j.ijpharm.2016.01.040_bib0320","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.biomaterials.2013.10.063","article-title":"A review of polypeptide-based polymersomes","volume":"35","author":"Zhao","year":"2014","journal-title":"Biomaterials"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316300400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316300400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T22:15:40Z","timestamp":1718316940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316300400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":64,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0378517316300400"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.040","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}